Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."
Published 2011-09-02 23:55:05
Updated 2017-08-29 01:30:11
Source MITRE
View at NVD,   CVE.org
Vulnerability category: Denial of service

Exploit prediction scoring system (EPSS) score for CVE-2011-3386

3.76%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 91 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2011-3386

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
4.0
MEDIUM AV:N/AC:H/Au:N/C:N/I:P/A:P
4.9
4.9
NIST

References for CVE-2011-3386

Products affected by CVE-2011-3386

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!